Core Viewpoint - Lin Qingxuan, a high-end domestic beauty brand, faces challenges in its IPO journey due to regulatory issues regarding its product claims and high sales expenses despite a high gross margin of 82.5% from its Camellia Oil product [1][2][5]. Group 1: Financial Performance - Lin Qingxuan's Camellia Oil, priced over 500 RMB, contributed 4.48 billion RMB in revenue in 2024, accounting for 37% of total revenue, with a gross margin of 82.5%, significantly higher than competitors like Proya (64.5%) and Pechoin (75.8%) [2][4]. - The company's sales expenses were 5.09 billion RMB, 4.87 billion RMB, and 6.88 billion RMB from 2022 to 2024, representing 73.66%, 60.37%, and 56.86% of revenue, respectively, which remains high compared to Proya's 47.88% and Shanghai Jahwa's 46.69% [2][3]. - Lin Qingxuan's net profit margin was only 15.4% in 2024, indicating profitability challenges despite high gross margins [2]. Group 2: Market Position and Expansion - Lin Qingxuan's store count increased from 366 to 506 between 2022 and 2024, with significant growth in new first-tier and second-tier cities, while online sales grew from 45.2% to 59.1% of total revenue [3][4]. - The brand holds a 1.4% market share in the high-end skincare segment, ranking 13th among top brands, and a 2.2% share in the anti-wrinkle market, placing it in the top ten [4][6]. Group 3: Regulatory and Competitive Challenges - The company faced regulatory scrutiny, receiving fines for false advertising regarding its anti-aging claims, with a total of over 200 complaints related to product efficacy and refund issues [1][4][6]. - Lin Qingxuan's pricing strategy is challenged by competitors like Proya and Winona, which offer lower-priced products, and the brand's online sales face increasing costs and lower margins compared to offline sales [4][6]. Group 4: Investment and Valuation - Lin Qingxuan's valuation dropped from 31.75 billion RMB in 2021 to 15.59 billion RMB in 2024, reflecting broader market trends and internal issues, with significant share reductions by early investors [5][6]. - The company has multiple agreements that could pressure its management to buy back shares if it fails to go public by the end of 2026, indicating potential financial strain [6][7].

Core Viewpoint - Lin Qingxuan, a pioneer in the skincare industry, is on the verge of an IPO in Hong Kong, positioning itself as a leading high-end domestic skincare brand in China, with significant growth in revenue and profitability [4][5][6]. Group 1: Company Overview - Lin Qingxuan has sold 30 million bottles of its "essence oil" over 13 years, showcasing its market education efforts [4]. - The company is projected to achieve a revenue of 1.2 billion yuan in 2024, with a gross margin of 82.5% [5]. - Lin Qingxuan's gross margin is competitive, second only to the high-end brand Mao Geping, and comparable to international brands like L'Oréal and Estée Lauder [5][6]. Group 2: Market Position and Strategy - Lin Qingxuan ranks first among high-end domestic skincare brands in China and is the only domestic brand in the top 15 high-end skincare brands [6]. - The brand emphasizes its high-end positioning in its prospectus, highlighting a shift in consumer confidence towards domestic brands [6][8]. - The company has a balanced product category distribution, with its flagship product, camellia oil, accounting for 37% of sales [18]. Group 3: Growth and Expansion - Lin Qingxuan's offline store count has grown from 366 to 506 in two years, with a compound annual growth rate of 17.6%, making it the fastest-growing high-end domestic skincare brand in terms of store count [23]. - The company has a strong online presence, with online revenue growing by 81.08% to 714 million yuan in 2024, accounting for 59.1% of total revenue [25]. - Lin Qingxuan's marketing strategy includes a focus on experiential retail and personalized skincare solutions, targeting high-income consumers [24]. Group 4: Innovation and R&D - The company has invested in R&D, with 42 core ingredients developed, and aims to deepen its technological capabilities in the camellia oil sector [32]. - Lin Qingxuan has established long-term supply agreements for camellia flowers and operates two factories in Shanghai, including a carbon-neutral facility [32]. - The brand's R&D expenditure is currently below industry standards, indicating room for improvement in innovation [37]. Group 5: Future Challenges and Vision - Lin Qingxuan aims to become a leading global cosmetics group, competing with established international brands [33]. - The company faces challenges in marketing expenses and needs to enhance its R&D investment to keep pace with industry leaders [36][37]. - The brand's future plans include expanding its product matrix and targeting younger demographics, indicating a strategic shift towards broader market appeal [37].